A citation-based method for searching scientific literature

Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
Times Cited: 1092



Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci, John K Wiencke, Margaret R Wrensch, Susan M Chang, Kyle M Walsh, Sua Myong, Jun S Song, Joseph F Costello. Science 2015
Times Cited: 285




List of shared articles



Times cited

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.
Nighat Noureen, Shaofang Wu, Yingli Lv, Juechen Yang, W K Alfred Yung, Jonathan Gelfond, Xiaojing Wang, Dimpy Koul, Andrew Ludlow, Siyuan Zheng. Nat Commun 2021
2


Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction.
Shalu Sharma, Ananda Kishore Mukherjee, Shuvra Shekhar Roy, Sulochana Bagri, Silje Lier, Meenakshi Verma, Antara Sengupta, Manish Kumar, Gaute Nesse, Deo Prakash Pandey,[...]. Cell Rep 2021
0

A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
Sounak Gupta, Chad M Vanderbilt, Yun-Te Lin, Jamal K Benhamida, Achim A Jungbluth, Satshil Rana, Amir Momeni-Boroujeni, Jason C Chang, Tiffany Mcfarlane, Paulo Salazar,[...]. J Mol Diagn 2021
1

Human TERT promoter mutations as a prognostic biomarker in glioma.
Branka Powter, Sarah A Jeffreys, Heena Sareen, Adam Cooper, Daniel Brungs, Joseph Po, Tara Roberts, Eng-Siew Koh, Kieran F Scott, Mila Sajinovic,[...]. J Cancer Res Clin Oncol 2021
0

Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer.
Vikas Kumar Bhari, Durgesh Kumar, Surendra Kumar, Rajeev Mishra. Biochem Biophys Rep 2021
0

The E-Twenty-Six Family in Hepatocellular Carcinoma: Moving into the Spotlight.
Tongyue Zhang, Danfei Liu, Yijun Wang, Mengyu Sun, Limin Xia. Front Oncol 2021
0

Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage.
Alexandra M Amen, Christof Fellmann, Katarzyna M Soczek, Shawn M Ren, Rachel J Lew, Gavin J Knott, Jesslyn E Park, Andrew M McKinney, Andrew Mancini, Jennifer A Doudna,[...]. Proc Natl Acad Sci U S A 2021
0

TERT Promoter Alterations in Glioblastoma: A Systematic Review.
Nathalie Olympios, Vianney Gilard, Florent Marguet, Florian Clatot, Frédéric Di Fiore, Maxime Fontanilles. Cancers (Basel) 2021
0

Interpretation of allele-specific chromatin accessibility using cell state-aware deep learning.
Zeynep Kalender Atak, Ibrahim Ihsan Taskiran, Jonas Demeulemeester, Christopher Flerin, David Mauduit, Liesbeth Minnoye, Gert Hulselmans, Valerie Christiaens, Ghanem-Elias Ghanem, Jasper Wouters,[...]. Genome Res 2021
0

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing. Proc Natl Acad Sci U S A 2021
0

Pan-cancer noncoding genomic analysis identifies functional CDC20 promoter mutation hotspots.
Zaoke He, Tao Wu, Shixiang Wang, Jing Zhang, Xiaoqin Sun, Ziyu Tao, Xiangyu Zhao, Huimin Li, Kai Wu, Xue-Song Liu. iScience 2021
0

TERT and its binding protein: overexpression of GABPA/B in high grade gliomas.
Efthymios Papazacharias, Saskia Kuhl, Gabriele Röhn, Lukas Görtz, Roland Goldbrunner, Marco Timmer. Oncotarget 2021
0

Non-coding driver mutations in human cancer.
Kerryn Elliott, Erik Larsson. Nat Rev Cancer 2021
0

Cancer regulatory variation.
Rebecca C Hennessey, Kevin M Brown. Curr Opin Genet Dev 2021
0

Synergistic activation of mutant TERT promoter by Sp1 and GABPA in BRAFV600E-driven human cancers.
Yongxing Wu, Liang Shi, Yuelei Zhao, Pu Chen, Rongrong Cui, Meiju Ji, Nongyue He, Maode Wang, Gang Li, Peng Hou. NPJ Precis Oncol 2021
1

The landscape and driver potential of site-specific hotspots across cancer genomes.
Randi Istrup Juul, Morten Muhlig Nielsen, Malene Juul, Lars Feuerbach, Jakob Skou Pedersen. NPJ Genom Med 2021
0

The transcription factor FLI1 promotes cancer progression by affecting cell cycle regulation.
Beiping Miao, Andrea S Bauer, Katrin Hufnagel, Yenan Wu, Marija Trajkovic-Arsic, Anna C Pirona, Nathalia Giese, Jussi Taipale, Jens T Siveke, Jörg D Hoheisel,[...]. Int J Cancer 2020
2

Telomere-related Markers for Cancer.
Xiaotian Yuan, Mingkai Dai, Dawei Xu. Curr Top Med Chem 2020
10